Infectious Diseases

Eur Rev Med Pharmacol Sci 2021; 25 (6): 2473-2474
DOI: 10.26355/eurrev_202103_25408

Comment on safety and efficacy of oral lopinavir/ritonavir in pediatric patients with coronavirus disease: a nationwide comparative analysis

M. Ceccarelli, P. Pavone, E. Venanzi Rullo, G. Nunnari
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (6): 2470-2472
DOI: 10.26355/eurrev_202103_25407

Ozone therapy may be an option for COVID-19 patients

M. Şahin, F. Eryilmaz, H.H. Keser Şahin
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (6): 2468-2469
DOI: 10.26355/eurrev_202103_25406

Leading cause of death in comparison to COVID-19 in Saudi Arabia

S. Bashir, N. Altwaijri, T.M. Al-Harbi, T. Abualait
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (6): 2464-2467
DOI: 10.26355/eurrev_202103_25391

Transparency of disinfectant and hand sanitizer contents in the context of COVID-19

N. Cimolai
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (5): 2449-2456
DOI: 10.26355/eurrev_202103_25286

The COVID-19 pandemic and contact tracing technologies, between upholding the right to health and personal data protection

G. Montanari Vergallo, S. Zaami, E. Marinelli
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (5): 2435-2448
DOI: 10.26355/eurrev_202103_25285

Early combination treatment with existing HIV antivirals: an effective treatment for COVID-19?

R.N. Dallocchio, A. Dessì, A. De Vito, G. Delogu, P.A. Serra, G. Madeddu
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (5): 2425-2434
DOI: 10.26355/eurrev_202103_25284

Impact of acute myocardial injury on prognosis in patients with COVID-19

S. Karahan, F. Katkat, S. Ozcan, I. Sahin, E. Okuyan
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (5): 2418-2424
DOI: 10.26355/eurrev_202103_25283

Low prevalence of SARS-CoV-2 infection in inflammatory bowel disease

L. Scucchi, B. Neri, L. Sarmati, M. Mossa, G. Sena, R. Massoud, C. Petruzziello, M. Musumeci, I. Marafini, E. Calabrese, E. Lolli, S. Bernardini, M. Andreoni, G. Monteleone, L. Biancone
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (5): 2415-2417
DOI: 10.26355/eurrev_202103_25282

Flight hormones as therapeutic target for novel Coronavirus infectious disease

S.-H. Ouyang, H. Su, J.-P. He, X.-X. Li, D.-M. Lu
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (5): 2409-2414
DOI: 10.26355/eurrev_202103_25281

Gene expression analysis identifies genes associated with SARS-COV-2 receptors, ACE2 and TMPRSS2, in normal human lung tissues

R.-W. Hu, C. Liu, J.-P. Gong, Z.-X. Cao
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (5): 2163-2165
DOI: 10.26355/eurrev_202103_25204

Our mind-body reactions to COVID-19

S. Bashir, M. Asim, E. Nasim
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (5): 2161-2162
DOI: 10.26355/eurrev_202103_25203

Reply Letter – “Safety and efficacy of oral lopinavir/ritonavir in pediatric patients with coronavirus disease: a nationwide comparative analysis”

A. De Vito, G. Madeddu
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (5): 2160-2160
DOI: 10.26355/eurrev_202103_25201

Author Correction: The dual role of anti-viral therapy in the treatment of Coronavirus disease 2019

J.-Y. Liu, M.-X. Hua, C.-J. Du, L. Pu, P. Xiang, C.-S. Li, H.-F. Xiong, X.-Z. Liu, Z.-H. Chen, W. Xie, A. Li
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (4): 2152-2153
DOI: 10.26355/eurrev_202102_25121

Commentary: Tele-COVID-19: does it improve the provision of health services?

A. Di Trana, F.P. Busardò, G. Ricci, A. Sirignano
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (4): 2146-2151
DOI: 10.26355/eurrev_202102_25120

Liver infection and COVID-19: the electron microscopy proof and revision of the literature

M. Pirisi, C. Rigamonti, S. D’Alfonso, M. Nebuloni, D. Fanni, C. Gerosa, G. Orrù, E. Venanzi Rullo, P. Pavone, G. Faa, L. Saba, R. Boldorini
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (4): 2131-2145
DOI: 10.26355/eurrev_202102_25119

The interplay between vitamin D and COVID-19: protective or bystander?

H.F. Hetta, K. Muhammad, E.A. El-Masry, A.E. Taha, E.A. Ahmed, C. Phares, H.A. Kader, Y. Waheed, A.M. Zahran, R. Yahia, A. Kh. Meshaal, G. El-Saber Batiha
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (4): 2123-2130
DOI: 10.26355/eurrev_202102_25118

SARS-CoV-2 and finding of vein thrombosis: can IMPROVE and IMPROVEDD scores predict COVID-19 outcomes?

S. Greco, G. Zenunaj, B. Bonsi, A. Bella, M. Lopreiato, F. Luciani, D. Pedrini, G. Vestita, E. Dalla Nora, A. Passaro
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (4): 2114-2122
DOI: 10.26355/eurrev_202102_25117

Acute cardiac injury and acute kidney injury associated with severity and mortality in patients with COVID-19

W.-X. Li, W. Xu, C.-L. Huang, L. Fei, X.-D. Xie, Q. Li, L. Chen
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (4): 2109-2113
DOI: 10.26355/eurrev_202102_25116

Web-mediated counseling to counteract the emotional impact of COVID-19 for women with interstitial cystitis/bladder pain syndrome

G. Marano, E. Gaetani, M. Marturano, G. Sani, A. Gasbarrini, G. Scambia, M. Mazza
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (4): 1770-1771
DOI: 10.26355/eurrev_202102_25067

Diagnosing SARS-CoV-2 associated myositis should not rely on the profile of myositis-specific antibodies alone

J. Finsterer
Free PDF Download